Yes, Yes!! A New Sexual Era: Female Viagra Set To Hit Shelves

Are you someone who finds it difficult to climax during sex? Your saviour might just have arrived on a pharmacy shelf near you.

Women who have difficulty to reach orgasm during sex could soon have help thanks to a medicated nasal spray…

Up to 30 per cent of women suffer from the condition known as anorgasmia, yet there are currently no approved treatments on the market.

The men got their sex kicks in 1998 with the erectile dysfunction drug, Viagra, and now scientists are developing a treatment that’s been nicknamed the ‘female Viagra’.

The treatment, called Tefina, needs to be administered in droplet sized doses via the nostrils two hours before sex and is expected to work for six hours.

The testosterone-based treatment is thought to boost sexual desire by activating relevant parts of the brain and increasing blood flow to the sexual organs.

Researchers said they don't expect any testosterone-aided side-effects such as acne, body hair growth or deepening of the voice. They added that there should be also no ill-effects if a woman doesn't have sex after administering the spray.

Professor Susan Davis from Monash University is leading a major study to test the effectiveness of the nasal spray.

“We anticipate the treatment will work like Viagra for women. Rather than a long-term, therapy-based approach, this drug can be taken when a woman anticipates sexual activity,” Professor Davis said.

“We have previously shown that for women with low sexual interest, testosterone therapy not only improves sexual desire and arousal, but also enhances a woman’s ability to reach orgasm.”

However, not everyone is happy with the new product. Fertility expert Dr Gordon thinks female sexuality is being exploited for commercial reasons and that a new treatment risks overlooking the real factors behind a woman's low sex drive.

“Men use sex to de-stress and women need to be de-stressed to have sex, so that’s a very complex emotional issue,” he told ONE News.

But the ‘female Viagra’ researcher Prof Davis insisted sexual dysfunction had important health implications for women.

“Through previous research, we have shown that women under 50, who are not experiencing sexual pleasure will still participate in sexual activity on average five times per month, primarily to maintain relationship harmony,” he said.

“Further, we have shown that women who report poor sexual functioning have lower wellbeing, despite not being depressed. Doctors have little to offer women who are experiencing anorgasmia, and this could be a breakthrough study for women who currently are frustrated by the lack of any treatment option.”

The Australian researchers are recruiting pre-menopausal women from four cities to take part in the trial.  The trial is also taking place in the U.S and Canada.

Looks like it could be the start of a new sexual era for a lot of women…